Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


29.01.2024

3 Aliment Pharmacol Ther
3 Am J Gastroenterol
1 Clin Exp Immunol
1 Dig Dis Sci
1 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
1 Gastroenterology
6 Inflamm Bowel Dis
1 J Clin Gastroenterol
7 J Crohns Colitis
2 J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. SAGAMI S, Kobayashi T
    Editorial: Extending upadacitinib induction dosing in ulcerative colitis-A delicate balance of efficacy and safety.
    Aliment Pharmacol Ther. 2024;59:579-580.
    PubMed        

  2. PANACCIONE R
    Editorial: Extending upadacitinib induction dosing in ulcerative colitis-A delicate balance of efficacy and safety. Author's reply.
    Aliment Pharmacol Ther. 2024;59:581-582.
    PubMed        

  3. VASUDEVAN A, Con D, De Cruz P, Sparrow MP, et al
    Clinical trial: Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study).
    Aliment Pharmacol Ther. 2024;59:504-514.
    PubMed         Abstract available


    Am J Gastroenterol

  4. CHETWOOD JD, Ko Y, Pudipeddi A, Kariyawasam V, et al
    Biological agents in the treatment of Crohn's disease: a propensity score-matched analysis from the prospective Persistence Australian National IBD Cohort (PANIC3) study.
    Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002679.
    PubMed         Abstract available

  5. BERINSTEIN JA, Karl T, Patel A, Dolinger M, et al
    Effectiveness of Upadacitinib for Patients with Acute Severe Ulcerative Colitis: A Multi-Center Experience.
    Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002674.
    PubMed         Abstract available

  6. TANDON P, Huang V, Feig DS, Saskin R, et al
    Recent Immigrants with Inflammatory Bowel Disease Have Significant Health-Care Utilization from Preconception to Postpartum: A Population Cohort Study.
    Am J Gastroenterol. 2024 Jan 23. doi: 10.14309/ajg.0000000000002668.
    PubMed         Abstract available


    Clin Exp Immunol

  7. MORET-TATAY I, Nos P, Iborra M, Rausell F, et al
    Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's disease.
    Clin Exp Immunol. 2024 Jan 22:uxad134. doi: 10.1093.
    PubMed         Abstract available


    Dig Dis Sci

  8. EIDELBERG A, Axelrad J, Chedid V, Ballou S, et al
    Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Jan 24. doi: 10.1007/s10620-023-08253.
    PubMed         Abstract available


    Dis Colon Rectum

  9. CHEN KA, Pak J, Agala CB, Stem JM, et al
    Factors Associated With Performing Ileal Pouch-Anal Anastomosis After Total Colectomy for Ulcerative Colitis.
    Dis Colon Rectum. 2024 Jan 25. doi: 10.1097/DCR.0000000000003130.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  10. KIRKIK D, Kalkanli Tas S, Tanoglu A
    Unraveling the blood microbiome: novel insights into inflammasome responses in Crohn's disease.
    Eur J Gastroenterol Hepatol. 2024 Jan 22. doi: 10.1097/MEG.0000000000002695.
    PubMed         Abstract available


    Gastroenterol Hepatol

  11. PEREZ JP, Ortiz JE, Franco Moreno AI, Plaza Santos MDR, et al
    Influence of HLA-DQA1 *05 on the loss of response to anti-TNF treatment in inflammatory bowel disease. Spanish cohort of real clinical practice.
    Gastroenterol Hepatol. 2024 Jan 22:S0210-5705(24)00020.
    PubMed        


    Gastroenterology

  12. HASHASH JG, Elkins J, Lewis JD, Binion DG, et al
    AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Gastroenterology. 2024 Jan 23:S0016-5085(23)05597.
    PubMed         Abstract available


    Inflamm Bowel Dis

  13. KATSOUDAS N, Tavakoli P, Wu N, Shapiro A, et al
    Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?
    Inflamm Bowel Dis. 2024 Jan 19:izad318. doi: 10.1093.
    PubMed         Abstract available

  14. KRASNOVSKY L, Weber AT, Gershuni V, Pettke E, et al
    Preoperative Exclusive Enteral Nutrition Is Associated With Reduced Skin and Soft Tissue and Intra-abdominal Infections in Patients With Crohn's Disease Undergoing Intestinal Surgery: Results from a Meta-Analysis.
    Inflamm Bowel Dis. 2024 Jan 23:izad304. doi: 10.1093.
    PubMed         Abstract available

  15. DUBINSKY MC, Charles L, Selmaj KW, Comi G, et al
    Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis.
    Inflamm Bowel Dis. 2024 Jan 24:izae011. doi: 10.1093.
    PubMed        

  16. NAMBU R, Miyazawa A, Yoshida M, Hara T, et al
    Long-term Efficacy and Safety of Tacrolimus Plus Ustekinumab Combination Therapy in Children With Steroid-refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2024 Jan 24:izae013. doi: 10.1093.
    PubMed        

  17. D'HAENS G, Higgins PDR, Peyrin-Biroulet L, Sands BE, et al
    Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials.
    Inflamm Bowel Dis. 2024 Jan 25:izae004. doi: 10.1093.
    PubMed         Abstract available

  18. ZAMANI M, Ebrahimtabar F, Alizadeh-Tabari S, Kasner SE, et al
    Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2024 Jan 25:izae012. doi: 10.1093.
    PubMed         Abstract available


    J Clin Gastroenterol

  19. VARMA A, Weinstein J, Seabury J, Rosero S, et al
    The Crohn's Disease-Health Index: Development and Evaluation of a Novel Outcome Measure.
    J Clin Gastroenterol. 2024 Jan 26. doi: 10.1097/MCG.0000000000001976.
    PubMed         Abstract available


    J Crohns Colitis

  20. KUO J, Uzunovic J, Jacobson A, Dourado M, et al
    Toxigenic Clostridium perfringens isolated from at-risk pediatric inflammatory bowel disease patients.
    J Crohns Colitis. 2024 Jan 24:jjae016. doi: 10.1093.
    PubMed         Abstract available

  21. DUAN M, Lu M, Diao Y, Cao L, et al
    Azathioprine plus exclusive enteral nutrition versus azathioprine monotherapy for the prevention of postoperative recurrence in patients with Crohn's disease: an open-label, single-centre, randomised controlled trial.
    J Crohns Colitis. 2024 Jan 22:jjae015. doi: 10.1093.
    PubMed         Abstract available

  22. YARUR AJ, Chiorean MV, Panes J, Jairath V, et al
    Achievement of clinical, endoscopic, and histologic outcomes in patients with ulcerative colitis treated with etrasimod, and association with fecal calprotectin and C-reactive protein: results from the Phase 2 OASIS trial.
    J Crohns Colitis. 2024 Jan 20:jjae007. doi: 10.1093.
    PubMed         Abstract available

  23. MAGRO F, Fernandes S, Patita M, Arroja B, et al
    The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients.
    J Crohns Colitis. 2024 Jan 19:jjae014. doi: 10.1093.
    PubMed         Abstract available


  24. Erratum to: Ustekinumab as Induction and Maintenance Therapy in Patients with Inflammatory Bowel Disease and Type II Autoimmune Pancreatitis: Report of Two Cases.
    J Crohns Colitis. 2024 Jan 19:jjae005. doi: 10.1093.
    PubMed        

  25. BITTERLIN T, Valibouze C, Lenne X, Bruandet A, et al
    Hospital surgical volume-outcome relationship of postoperative morbidity for ileocolic resection in Crohn's disease: A French nationwide study of 4,205 patients.
    J Crohns Colitis. 2024 Jan 18:jjae010. doi: 10.1093.
    PubMed         Abstract available

  26. TAL N, Tzivinikos C, Gasparetto M, Serban DE, et al
    Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN.
    J Crohns Colitis. 2023;17:1939-1948.
    PubMed         Abstract available


    J Gastroenterol

  27. NAGANUMA M, Nakamura N, Kunisaki R, Matsuoka K, et al
    Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria.
    J Gastroenterol. 2024 Jan 26. doi: 10.1007/s00535-024-02079.
    PubMed         Abstract available

  28. KOMATSU H, Morikubo H, Kimura Y, Moue C, et al
    A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion.
    J Gastroenterol. 2024 Jan 21. doi: 10.1007/s00535-024-02077.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.